Aniruddha Sarkar

Employment

• Dana-Farber Cancer Institute Post doctoral fellow
  2020 - 2024

Education

Education history is unavailable.

Projects & Funding

Projects & funding information is unavailable.

Publications (9)

• Targeting G1–S-checkpoint-compromised cancers with cyclin A/B RxL inhibitors
  Nature 2025 DOI: 10.1038/s41586-025-09433-w
  +Save
• NEAT1 modulates the TIRR/53BP1 complex to maintain genome integrity
  Nature Communications 2024 DOI: 10.1038/s41467-024-52862-w
  +Save
• CDK5–cyclin B1 regulates mitotic fidelity
  Nature 2024 DOI: 10.1038/s41586-024-07888-x
  +Save
• Data from Ecdysoneless Overexpression Drives Mammary Tumorigenesis through Upregulation of C-MYC and Glucose Metabolism
  2023 DOI: 10.1158/1541-7786.c.6545604.v1
  +Save
• Data from Ecdysoneless Overexpression Drives Mammary Tumorigenesis through Upregulation of C-MYC and Glucose Metabolism
  2023 DOI: 10.1158/1541-7786.c.6545604
  +Save
• Supplementary Data from Ecdysoneless Overexpression Drives Mammary Tumorigenesis through Upregulation of C-MYC and Glucose Metabolism
  2023 DOI: 10.1158/1541-7786.22528065.v1
  +Save
• Supplementary Data from Ecdysoneless Overexpression Drives Mammary Tumorigenesis through Upregulation of C-MYC and Glucose Metabolism
  2023 DOI: 10.1158/1541-7786.22528065
  +Save
• Ecdysoneless Overexpression Drives Mammary Tumorigenesis through Upregulation of C-MYC and Glucose Metabolism
  Molecular Cancer Research 2022 DOI: 10.1158/1541-7786.MCR-22-0122
  +Save
• Endogenous oxidized DNA bases and APE1 regulate the formation of G-quadruplex structures in the genome
  Proceedings of the National Academy of Sciences 2020 DOI: 10.1073/pnas.1912355117
  +Save